Toronto Dominion Bank
URGN icon

Toronto Dominion Bank’s UroGen Pharma URGN Stock Holding History

Toronto Dominion Bank’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47M Buy
+2,616,714
New +$52.5M 0.09% 249
2025
Q4 		– Sell
-3,190,510
Closed -$63.7M – 2306
2025
Q3 		$63.7M Hold
3,190,510
– – 0.12% 193
2025
Q2 		$43.7M Buy
3,190,510
+1,441,368
+82% +$13.8M 0.09% 226
2025
Q1 		$19.3M Hold
1,749,142
– – 0.05% 334
2024
Q4 		$18.6M Buy
+1,749,142
New +$20.9M 0.04% 360
2024
Q3 		– Sell
-6
Closed -$101 – 1446
2024
Q2 		$101 Hold
6
– – ﹤0.01% 1353
2024
Q1 		$90 Hold
6
– – ﹤0.01% 1339
2023
Q4 		$90 Hold
6
– – ﹤0.01% 1470
2023
Q3 		$84 Buy
+6
New +$96 ﹤0.01% 1694

Other funds holding URGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
JFG
Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $90.6B AUM 36.98% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return